Daniel Shepshelovich

7PUBLICATIONS
24CO-AUTHORS
PharmacogenomicsClinical sciences not elsewhere classifiedEpidemiological methodsNanotoxicology, health and safetySolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 25, 2024
Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review.

Bronya Calvarysky, Idit Dotan, Daniel Shepshelovich

|Feb 22, 2021
Underreporting of Symptomatic Adverse Events in Phase I Clinical Trials.

Zachary W Veitch, Daniel Shepshelovich, Christina Gallagher

|Feb 12, 2021
Incidence of lung cancer following pneumonia in smokers: a population-based study.

D Shepshelovich, N Barda, H Goldvaser

|Dec 03, 2020
Vaccine safety - is the SARS-CoV-2 vaccine any different?

Noam Tau, Dafna Yahav, Daniel Shepshelovich

|Nov 10, 2019
Characterization and outcomes of patients enrolled to multiple phase I cancer trials.

Nathan Kuehne, Lina Chen, Kate McDonald

|Jul 03, 2019
Investigation of Leukocyte Telomere Length and Genetic Variants in Chromosome 5p15.33 as Prognostic Markers in Lung Cancer.

Linda Kachuri, Jens Helby, Stig Egil Bojesen

Pageof 2